Public Company News

Agoda Unveils Ranking of Asia's Top Rural Destinations: Highland Tourism on the Rise

SINGAPORE, Sept. 15, 2025 /PRNewswire/ -- Digital travel platform Agoda has announced its list of top rural destinations inAsia, offering travelers a chance to explore beyond bustling big-city hotspots.Malaysia's lush Cameron Highlands took the crown for the most popular rural destination inAs...

2025-09-15 10:05 2244

SM named among TIME's World's Best Companies for second year

PASAY CITY, Philippines, Sept. 15, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments), the parent firm of the SM group, has once again been recognized by TIME and Statista on the prestigious "World's Best Companies 2025" list. This marks the second consecutive year that SM Investmen...

2025-09-15 09:06 2104

EverBridge Group and Cosmotec Forge Landmark Partnership

SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary of M3, Inc.; TSE: 2413) for the Japanese market. Jay Wang (Left) and Suguru Ominato ...

2025-09-15 08:00 3756

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts at the 18th International lgAN Symposium

* 7 new NEFECON® real-world evidence abstracts will be presented at the 18th  International lgA Nephropathy Symposium (IIgANN 2025). * The newly released results, based on clinical practices at several leading hospitals inChina, offer a comprehensive overview of the efficacy and safety of NEFE...

2025-09-15 07:45 5669

30+ Anniversary Celebration - Crafting Happiness with Artistry

HONG KONG, Sept. 13, 2025 /PRNewswire/ -- Casa means "home" in Italian, and "Dream Casa Love Casa" means "everyone dreams and strives to create the image of their desired and beloved home".Casablanca adhering to the design philosophy of "fashion, creativity, and functionality", we have been creat...

2025-09-13 12:00 1303

NYSE Content Advisory: Pre-Market Update + Via prices IPO above range at $46

NEW YORK, Sept. 12, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Via prices IPO above...

2025-09-12 20:55 6346

Invitation to showcase of tidal energy kite 'Dragon 4' at Minesto workshop in Gothenburg, 8 October 2025

GOTHENBURG, Sweden, Sept. 12, 2025 /PRNewswire/ -- Minesto invites investors and the public with an interest in technology, energy systems and climate innovations to a unique opportunity to experience firsthand the tidal energy kite Dragon 4 'Íðunn' as she is brought home for a break from product...

2025-09-12 18:53 2419

Zoomlion Delivers its First Germany-Made Knuckle Boom Crane, Strengthening European Localization Strategy

FRANKFURT, Germany, Sept. 12, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion") today announced the successful rollout and delivery of its first knuckle boom crane from its Wilbert subsidiary factory inGermany. The delivery to a Slovak customer marks another...

2025-09-12 16:46 7972

Fosun International Achieves AA- in HSI ESG Rating for Third Consecutive Year, Marks Sixth Year as Constituent of Hang Seng Corporate Sustainability Benchmark Index

HONG KONG, Sept. 12, 2025 /PRNewswire/ -- On 9 September 2025, Fosun International Limited (HKEX stock code: 00656, hereinafter referred to as "Fosun International" or the "Company") was informed that in the 2025 Sustainability Ratings of listed companies released by Hang Seng Indexes Company, F...

2025-09-12 15:58 5984

Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig

NANJING, China, Sept. 12, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the first patient has been successfully dosed in a Phase1b/II clinical trial (NCT07099430) evaluating Opamtistomig (LBL-024, PD-L1/4-1BB bispecifi...

2025-09-12 12:39 3855

The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration

SUZHOU, China, Sept. 12, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharm...

2025-09-12 09:51 2073

Aker Horizons ASA: The merger between Aker Horizons Holding AS and AKH HoldCo AS is completed

FORNEBU, Norway, Sept. 12, 2025 /PRNewswire/ -- Reference is made to the previous announcements made by Aker Horizons ASA (the "Company" or "Aker Horizons") regarding the merger between its subsidiary, Aker Horizons Holding AS ("AKHH"), and AKH HoldCo AS ("AKH HoldCo"), a subsidiary of Aker ASA (...

2025-09-12 04:25 2394

Supermicro Begins Volume Shipments of NVIDIA Blackwell Ultra Systems and Rack Plug-and-Play Data Center-Scale Solutions

* Now delivering high volume NVIDIA HGX B300 systems and NVIDIA GB300 NVL72 in volume to customers worldwide * Enabling turn-key day-one operation by delivering pre-validated solutions at system, rack, and data center-scale through Supermicro Data Center Building Block Solutions® (DCBBS) * ...

2025-09-12 04:05 3335

Infosys and HanesBrands Inc. Collaborate to Unlock Hyper Productivity and AI-Driven Efficiency

Ten-year alliance leverages Infosys AI-first platforms to drive innovation, efficiency and agility across HanesBrands' IT Landscape BENGALURU, India, Sept. 11, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation ...

2025-09-11 21:21 2327

NYSE Content Advisory: Pre-Market Update + Trading community honors victims on 9/11

NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Trading community ho...

2025-09-11 20:58 3995

Corero Network Security Partners with Nextwave to Expand DDoS Protection into Thailand

LONDON, Sept. 11, 2025 /PRNewswire/ -- Today, Corero Network Security (AIM: CNS) (OTCQX: DDOSF), a recognized leader in DDoS protection and champion of adaptive, real-tim...

2025-09-11 19:00 4245

SKF earns top CDP ratings, reinforcing climate leadership across the value chain

GOTHENBURG, Sweden, Sept. 11, 2025 /PRNewswire/ -- SKF has been awarded an `A' score in the 2024 CDP Supplier Engagement Assessment (SEA), placing the company among the global leaders in supplier climate action and transparency. This recognition follows SKF's earlier A rating for Climate from CDP...

2025-09-11 15:51 2078

lululemon's Dr. Joey Chan Explores Innovation at Retail Asia Conference & Expo 2025

Spotlighting lululemon's commitment to innovation and community engagement as key drivers shaping the future of retail inAsia HONG KONG, Sept. 11, 2025 /PRNewswire/ -- lululemon is proud to have had Dr. Joey Chan, Market Director for Hong Kong, Macau, and Taiwan, as a panelist on "Retail Reimagi...

2025-09-11 15:34 2936

JINGDONG Industrials and Kawan Lama Group Hold In-Depth Talks on Building Indonesia's Industrial Supply Chain

BEIJING, Sept. 11, 2025 /PRNewswire/ -- JINGDONG Industrials, a subsidiary of JD.com, andIndonesia's Kawan Lama Group, held productive discussions in Beijing last week to advance Indonesia's supply chain infrastructure through digital and intelligent solutions, aligning withSoutheast Asia's indu...

2025-09-11 15:17 3912

Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

* Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb) *...

2025-09-11 14:56 1881
1 ... 159160161162163164165 ... 901

Week's Top Stories